Nadia Dac insider trades

Open-market stock purchases and sales by Nadia Dac, Chief Commercial Officer at Kyverna Therapeutics, Inc, from SEC Form 4 filings since Apr 8, 2019.

Recent trades

DateStockTradeValue
May 4, 2026KYTX Kyverna Therapeutics, IncBought (not open market)—

Companies traded

  • KYTX Kyverna Therapeutics, Inc: other filings, last May 4, 2026
  • ALDR Alder Biopharmaceuticals Inc: other filings, last Oct 22, 2019

Get free alerts when Nadia Dac files a new trade →